Filtration function in glomerulonephritis

Slides:



Advertisements
Similar presentations
Jack DeRuiter, PhD Department of Pharmacal Sciences April, 2000
Advertisements

Glomerular Filtration Rate (GFR) (GFR) DR. Khaled Khalil.
The Renal Pathology of Obesity
L. Aya M. Serry Glomerulonephritis 2017
Jack DeRuiter, PhD Department of Pharmacal Sciences April, 2000
Volume 64, Issue 6, Pages (December 2003)
Volume 70, Issue 10, Pages (November 2006)
Volume 82, Issue 2, Pages (July 2012)
Uric Acid as a Target of Therapy in CKD
Dylan Burger, Adeera Levin  Kidney International 
Monoclonal Gammopathy–Associated Proliferative Glomerulonephritis
Nat. Rev. Nephrol. doi: /nrneph
Anti-glomerular basement membrane disease
C. J. Ilse Raats, Jacob Van Den Born, Jo.H.M. Berden, M.D., Ph.D. 
Volume 85, Issue 3, Pages (March 2014)
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
Volume 54, Issue 6, Pages (January 1998)
Burden of chronic kidney disease: North Africa
Proteinuria: an enzymatic disease of the podocyte?
Hans-Joachim Anders, Volker Vielhauer, Detlef Schlöndorff 
The impact of cold ischemia time on renal transplant outcome
The intrarenal renin-angiotensin system in hypertension
Volume 54, Issue 6, Pages (January 1998)
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
Volume 79, Issue 1, Pages (January 2011)
Figure 1 Principal pathogenic mechanisms of
Wilhelm Kriz, Michel Lehir  Kidney International 
Postinfectious Glomerulonephritis
Anemia management and chronic renal failure progression
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
An update on the pathogenesis and treatment of IgA nephropathy
Volume 69, Issue 12, Pages (June 2006)
A personal hypothetical mechanistic interpretation of idiopathic MN
Macrophages and hypoxia in human chronic kidney disease
Renal basement membrane components
ANCA-associated renal vasculitis
Volume 72, Issue 2, Pages (July 2007)
Time to abandon microalbuminuria?
AJKD Atlas of Renal Pathology: Minimal Change Disease
Volume 71, Issue 12, Pages (June 2007)
Joshua D. Ooi, A. Richard Kitching  Kidney International 
Counteracting progression of renal disease: A look into the future
Simplified diagrammatic representation of a selection of mechanisms of glomerular injury. Simplified diagrammatic representation of a selection of mechanisms.
Tubulointerstitial damage and progression of renal failure
Volume 62, Issue 4, Pages (October 2002)
Tatsumi Moriya, Thomas J. Groppoli, Youngki Kim, Michael Mauer 
Volume 81, Issue 8, Pages (April 2012)
Volume 65, Issue 3, Pages (March 2004)
Determinants of glomerular hypofiltration in aging humans
It's not over till the last glomerulus forms
Karen A. Griffin, Anil K. Bidani  Kidney International 
Volume 82, Issue 9, Pages (November 2012)
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
Endothelial cell activation
Changbin Qiu, Chris Baylis  Kidney International 
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 80, Issue 10, Pages (November 2011)
Cellular contributions to glomerular size-selectivity
Is complement a target for therapy in renal disease?
Volume 71, Issue 12, Pages (June 2007)
A nest in renal fibrosis?
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
Volume 75, Issue 7, Pages (April 2009)
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 56, Issue 6, Pages (December 1999)
Niamh E. Kieran, Paola Maderna, Catherine Godson  Kidney International 
Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis
Proteinuria and hypertension with tyrosine kinase inhibitors
Podocyte GTPases regulate kidney filter dynamics
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Presentation transcript:

Filtration function in glomerulonephritis Kamal F. Badr  Kidney International  Volume 68, Issue 4, Pages 1905-1919 (October 2005) DOI: 10.1111/j.1523-1755.2005.00610.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 The pathophysiology of proteinuria and of decreased glomerular filtration rate (GFR) during glomerulonephritis. Podocyte injury results from direct complement binding and from activation (*) of glomerular and infiltrating cells, leading to proteinuria, the magnitude of which is amplified by elevations in single nephron plasma flow rates (QA) and glomerular capillary pressure (PGC). The fall in GFR is attributed to reductions in the filtering surface area (and possibly other) components of the glomerular capillary ultrafiltration coefficient (Kf), which can result from reversible mesangial cell (MC) contraction, irreversible structural damage, or a combination of both. Abbreviations are: ROS, reactive oxygen species; TxA2, thromboxane A2; GFs, growth factors; NO, nitric oxide; GEN, glomerular endothelial cells; PMN, polymorphonuclear cells; MPh, macrophages; IC, immune complex; GBM, glomerular basement membrane. Kidney International 2005 68, 1905-1919DOI: (10.1111/j.1523-1755.2005.00610.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Podocyte injury in glomerulonephritis. Summary of the current literature on established complement and cell activation-dependent mediators of podocyte injury and target proteins on the podocyte and the slit diaphragm which have been associated with congenital or acquired proteinuria11-33. Note that mechanical stress imposed by elevations in single nephron plasma flow rate (QA) and glomerular capillary pressure (PGC) results from vasoactive locally released products of cellular activation4-10, as well as the adaptive responses to progressive nephron loss. See Figure 1 and text for abbreviations. Kidney International 2005 68, 1905-1919DOI: (10.1111/j.1523-1755.2005.00610.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 (A) Individual glomeruli in patients with glomerulonephritis fall into one of four histopathologic patterns: normal, inflammation without fibrosis, a combination of inflammation and fibrosis in the same glomerulus, and fibrosis with loss of architectural integrity. (B) The rates at which glomerular filtration rate (GFR) is lost can vary infinitely and are described by a family of curves (r1 to rn). A 50% reduction in GFR, however, may result solely from reversible reductions in Kf (A), irreversible reductions in Kf (C), or a combination of both (B) (See Figure 2). (c) Dynamic evolution of the principal mechanism underlying the fall in total GFR over the course of glomerular inflammatory injury as individual glomeruli transition from stage II to stage IV. Essential to the choice of therapy (anti-inflammatory, anti-fibrotic, or none) is valid quantitative measurements of the proportion of nephrons in each stage (see hypothetical profiles described in text). ESRD is end-stage renal disease; SNGFR is single-nephron GFR. Kidney International 2005 68, 1905-1919DOI: (10.1111/j.1523-1755.2005.00610.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Kidney International 2005 68, 1905-1919DOI: (10. 1111/j. 1523-1755 Kidney International 2005 68, 1905-1919DOI: (10.1111/j.1523-1755.2005.00610.x) Copyright © 2005 International Society of Nephrology Terms and Conditions